Gibson T, Emery P, Armstrong R D, Crisp A J, Panayi G S
Br J Rheumatol. 1987 Aug;26(4):279-84. doi: 10.1093/rheumatology/26.4.279.
Seventy-two patients with relatively early but progressive rheumatoid arthritis were treated with chloroquine sulphate, D-penicillamine or a combination of both drugs over 1 year. Chloroquine resulted in significantly fewer side-effects but combined treatment appeared to increase the risks of toxicity. Significant clinical improvements were seen with each regimen and these were indistinguishable between treatments. However, chloroquine had less impact on haemoglobin, ESR, rheumatoid factor levels and C-reactive protein than the other treatments. Furthermore, radiological deterioration was most frequent amongst those given chloroquine alone. Combination treatment with D-penicillamine and chloroquine thus offered no advantages. Chloroquine caused fewer side-effects than both D-penicillamine and combination treatment but appeared to have a less pronounced effect on the disease process as measured by laboratory and radiological indices.
72例相对早期但病情进展的类风湿关节炎患者接受硫酸氯喹、D-青霉胺或两种药物联合治疗1年。氯喹产生的副作用明显较少,但联合治疗似乎增加了毒性风险。每种治疗方案都有显著的临床改善,且各治疗组之间无明显差异。然而,与其他治疗相比,氯喹对血红蛋白、血沉、类风湿因子水平和C反应蛋白的影响较小。此外,单独使用氯喹的患者中放射学恶化最为常见。因此,D-青霉胺与氯喹联合治疗没有优势。氯喹产生的副作用比D-青霉胺和联合治疗都少,但从实验室和放射学指标衡量,其对疾病进程的影响似乎不那么显著。